Clinical Trials
25 trialsNCT06410625 2024-05-16
FLT-MM
Ankara University
Phase NA Unknown
NCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT04823741 2024-02-01
SCITH-MESO
Hospices Civils de Lyon
Unknown
NCT05910112 2023-06-18
PROSPECT
University of Oxford
Unknown
NCT03654833 2023-03-14
MiST
University of Leicester
Phase 2 Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT05508555 2022-08-22
Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma
Ain Shams University
Phase NA Unknown
NCT05077111 2021-10-14
VATS
Ain Shams University
Phase 4 Unknown
NCT04713761 2021-01-26
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT04462809 2020-07-09
TALAMESO
Hospices Civils de Lyon
Phase 2 Unknown
NCT03210298 2019-10-08
PIPACRegis
University of Magdeburg
Unknown
NCT03558932 2018-06-15
IP3R Modulation by Cancer Genes in Mesothelioma
KU Leuven
Unknown
NCT02761863 2018-02-23
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Unknown
NCT03290183 2017-09-21
Confocal Laser Endomicroscopy in Pleural Malignancies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Unknown
NCT02755675 2016-11-21
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02588131 2015-10-27
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Italian Network for Tumor Biotherapy Foundation
Phase 2 Unknown
NCT02580747 2015-10-20
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Phase 1 Unknown
NCT00969098 2015-08-06
Response Evaluation in Malignant Pleural Mesothelioma
Istituto Clinico Humanitas
Unknown
NCT02497053 2015-07-14
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
Ain Shams University
Phase 2 Unknown
NCT01279967 2014-11-20
ADAM
Barts & The London NHS Trust
Phase 2 Unknown
NCT01655888 2012-08-02
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown
NCT01649024 2012-07-25
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown
NCT00996385 2011-10-31
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Phase 2 Unknown
NCT01343264 2011-04-28
Trimodality Therapy for Malignant Pleural Mesothelioma
HSK Wiesbaden
Unknown